共查询到18条相似文献,搜索用时 156 毫秒
1.
生物可降解聚合物/药物纳米微粒在药物靶向递送、有效成分封装和医疗诊断等领域具有突出的优势。超临界流体超细微粒制备技术具有绿色环保、制备方法种类多、粒径易调节和后续分离纯化容易等特点,得到了广泛的研究。为了得到满足使用要求的聚合物/药物纳米微粒,超临界流体制粒技术是有效的手段之一。论述了生物可降解聚合物纳米材料的特点和应用情况,简要介绍了超临界流体及特性,重点介绍了超临界溶液快速膨胀(RESS)、超临界抗溶剂沉淀(SAS)、超临界CO2辅助雾化(SAA)和超临界流体乳液萃取(SFEE)的工艺特点、制备方法、基本原理和研究进展,并对超临界流体技术制备聚合物/药物纳米微粒的发展方向进行了展望。 相似文献
2.
3.
超临界流体药物微粒化技术的研究进展 总被引:1,自引:0,他引:1
超细微粒特别是纳米粒子的研制,已成为药物输送系统研究中的一个热门领域。控制药物微粒的粒径和粒径分布,能够提高或改善药物的药效、增加药物的靶向性等作用,因此药物微粒化技术越来越受到制药行业的广泛关注。本文对超临界流体药物微粒化技术的研究进行了综述。 相似文献
4.
超临界流体辅助雾化法(SAA)是一种新型的以超临界流体为基础的固体微粒制备工艺,既能用于水溶性,也可用于脂溶性的溶质.该工艺能制备出适用于气溶胶给药要求的微粒,预期可在药物行业内得到应用.综述了SAA过程的形成和特色、工艺流程和操作条件以及相应的造粒结果.评述了6种药物微粒的粒度、粒度分布及其形貌.经SAA加工后的药物质量未见变化,目前该工艺已进入中试阶段,展示出较快的发展速度.比较了SAA和现有的主要以超临界流体为基础的微粒制造工艺.展望了加强应用基础研究的必要性,进一步分析了SAA的机理和过程实质. 相似文献
5.
6.
介绍了超临界流体(SCF)技术制备复合载药微粒的原理、特点,总结了近几年SCF技术在制备药物复合微粒方面的研究情况,并就超临界流体技术应用于药物制剂方面的前景进行了探讨。 相似文献
7.
8.
9.
10.
11.
Islane Espírito Santo André S?o Pedro Rosana Fialho Elaine Cabral-Albuquerque 《Nanoscale research letters》2013,8(1):386
The interest of the pharmaceutical industry in lipid drug delivery systems due to their prolonged release profile, biocompatibility, reduction of side effects, and so on is already known. However, conventional methods of preparation of these structures for their use and production in the pharmaceutical industry are difficult since these methods are usually multi-step and involve high amount of organic solvent. Furthermore, some processes need extreme conditions, which can lead to an increase of heterogeneity of particle size and degradation of the drug. An alternative for drug delivery system production is the utilization of supercritical fluid technique. Lipid particles produced by supercritical fluid have shown different physicochemical properties in comparison to lipid particles produced by classical methods. Such particles have shown more physical stability and narrower size distribution. So, in this paper, a critical overview of supercritical fluid-based processes for the production of lipid micro- and nanoparticles is given and the most important characteristics of each process are highlighted. 相似文献
12.
超临界抗溶剂造粒技术由于具有操作条件温和、制得的微粒有机溶剂残留少、微粒粒径和形态可控等优点,已广泛地应用于药物运输体系的研究当中。本文简要介绍了超临界抗溶剂造粒技术的基本原理、装置组成和基本分类;从技术发展、喷嘴改进、技术结合、产品收集等方面,详细阐述了GAS、ASES、SEDS、SEDS-PA、SpEDS、SAS-EM、SAS-IJ、连续式RESS以及RESAS等基于超临界流体抗溶剂原理的造粒技术及其装置的改进过程;然后对目前其中存在的颗粒团聚、产品收集难和装置资源没有充分利用等问题提出了可能的解决方案;最后从数学模型的建立和规模化两方面,对超临界抗溶剂造粒技术基础理论的完善及其装置的改进进行了展望。 相似文献
13.
超临界溶液浸渍法(supercritical solution impregnation,SSI)是一种将小分子物质负载到聚合物中的过程技术,主要是利用超临界流体的高扩散系数、低黏度及其对聚合物的溶胀作用,使小分子物质通过分子扩散作用迅速进入溶胀的聚合物并包裹于其中。近年来该技术已用于制备缓释药物/聚合物复合微球、薄膜和纤维等。该法的主要优点在于载体结构灵活,拓展了超临界技术在控释药物制备中的应用。本文主要介绍了SSI法的原理、流程及其在缓释药物制备中的应用,并展望了SSI法的发展趋势。 相似文献
14.
15.
全灿 《中国化学工程学报》2009,17(2):344-349
Based on the solubility in supercritical CO2, two strategies in which CO2 plays different roles are used to make quercetine and astaxanthin particles by supercritical fluid technologies. The experimental results showed that micronized quercetine particles with mean particle size of 1.0-1.5 µm can be made via solution enhanced dis-persion by supercritical fluids (SEDS) process, in which CO2 worked as turbulent anti-solvent; while for astaxan-thin, micronized particles with mean particle size of 0.3-0.8 µm were also made successfully by rapid expansion supercritical solution (RESS) process. 相似文献
16.
Xiaohui HuYanni Guo Lei WangDan Hua Yanzhen HongJun Li 《The Journal of Supercritical Fluids》2011,57(1):66-72
A supercritical fluid-based method is proposed to produce coenzyme Q10 (CoQ10) nanoparticles. First, CoQ10/polyethylene glycol 6000 composite particles are prepared by a modified PGSS (particles from gas-saturated solutions) process with controlling the flow rate of the gas-saturated solution. Then, CoQ10 nanoparticles are obtained by dissolving the composite particles into water. The effect of experimental variables of the modified PGSS process, including pressure, temperature, flow rate of the gas-saturated solution, and mass fraction of CoQ10, on the CoQ10 particle size and particle size distribution was investigated. Results show that CoQ10 slurry product with a median diameter of 190 nm and yield of 89.8% can be prepared at an optimum condition (operating pressure of 25 MPa, operating temperature of 80 °C, gas-saturated solution flow rate of 1.02 mL/min, CoQ10 mass fraction of 40% and nozzle diameter of 100 μm) via the supercritical fluid-based method. 相似文献
17.
18.
Dissolution rate enhancement of the anti-inflammatory drug diflunisal was achieved using for the first time a supercritical fluid technology. The supercritical fluid antisolvent (SAS) method was applied to precipitate diflunisal alone and to coprecipitate the drug together with the biocompatible polymer polyvinylpyrrolidone (PVP K-30 and K-10). The untreated and SAS processed diflunisal, and the coprecipitates were characterized in terms of size, morphology, crystallinity, compositions, drug-polymer interactions, and drug release. SAS processed diflunisal exhibited a polymorphic form different from that of the untreated drug. Diflunisal crystallinity disappeared in the coprecipitates. Three different drug: polymer mass ratios were studied: 75:25, 50:50, and 25:75. Microparticle size decreased and aggregation disappeared as the relative amount of polymer increased. The 25:75 coprecipitate consisted of loose spherical particles exhibiting mean particle size of 410 nm while the 75:25 coprecipitate consisted of bigger aggregated particles. The SAS method was shown to be a suitable technology to form solid dispersions of a poorly soluble drug. 相似文献